Bihi Pharmaceuticals engages with selected distributors and partners across the Middle East, North Africa, and African markets through structured, licensing-based collaboration models.
Bihi Pharmaceuticals operates through a disciplined, partner-driven model. We collaborate with a limited number of qualified partners aligned with regulatory integrity, manufacturing quality, and long-term commercial objectives.
All engagements are conducted through structured processes, including NDA-based discussions and clearly defined roles and responsibilities.
Partnerships are structured on a country-exclusive basis to ensure focused regulatory execution and sustainable market development.
Local partners lead product registration and market authorization in alignment with national regulatory requirements.
Commercial structures are designed to align incentives through transparent, royalty-based or supply-linked models.
Bihi Pharmaceuticals is actively engaging with partners across the Middle East, North Africa, and selected African markets.
Initial commercial focus includes Saudi Arabia, GCC countries, and selected African markets where demand for ophthalmic and essential medicines is well established.